Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
T-Type Calcium Channels: A Potential Novel Target in Melanoma
by
Barceló, Carla
, de la Rosa, Inés
, Macià, Anna
, Martí, Rosa M.
, Maiques, Oscar
, Sisó, Pol
in
Review
2020
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
T-Type Calcium Channels: A Potential Novel Target in Melanoma
by
Barceló, Carla
, de la Rosa, Inés
, Macià, Anna
, Martí, Rosa M.
, Maiques, Oscar
, Sisó, Pol
in
Review
2020
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
T-Type Calcium Channels: A Potential Novel Target in Melanoma
Journal Article
T-Type Calcium Channels: A Potential Novel Target in Melanoma
2020
Request Book From Autostore
and Choose the Collection Method
Overview
T-type calcium channels (TTCCs) are overexpressed in several cancers. In this review, we summarize the recent advances and new insights into TTCC biology, tumor progression, and prognosis biomarker and therapeutic potential in the melanoma field. We describe a novel correlation between the Cav3.1 isoform and the increased basal autophagy in BRAFV600E-mutant melanomas and after acquired resistance to BRAF inhibitors. Indeed, TTCC blockers reduce melanoma cell viability and migration/invasion in vitro and tumor growth in mice xenografts in both BRAF-inhibitor-sensitive and -resistant scenarios. These studies open a new, promising therapeutic approach for disseminated melanoma and improved treatment in BRAFi relapsed melanomas, but further validation and clinical trials are needed for it to become a real therapeutic option.
Publisher
MDPI
Subject
This website uses cookies to ensure you get the best experience on our website.